Search results for "microRNA"

showing 10 items of 577 documents

<i>MYC</i> Dosage Compensation is Mediated by miRNA-Transcription Factor Interactions in Aneuploid Cancer

2021

Cancer complexity is consequence of genomic instability leading to aneuploidy. We hypothesize that dosage compensation of critical genes arise from systems-level properties for cancer cells to withstand the negative effects of aneuploidy. We developed a computational platform to identify a network of miRNAs and transcription factors interacting with candidate dosage-compensated genes using NCI-60 multi-omic data. We next constructed a mathematical model where the property of dosage compensation emerged for MYC and STAT3 and was dependent on the kinetic parameters of their feedback and feed-forward interactions with four miRNAs. We developed a genetic tug-of-war approach by overexpressing an…

Genome instabilityDosage compensationColorectal cancermicroRNACancer cellCancer researchmedicineCancerBiologymedicine.diseaseGene dosageTranscription factorSSRN Electronic Journal
researchProduct

MYC dosage compensation is mediated by miRNA-transcription factor interactions in aneuploid cancer

2021

SummaryWe hypothesize that dosage compensation of critical genes arises from systems-level properties for cancer cells to withstand the negative effects of aneuploidy. We identified several candidate genes in cancer multi-omics data and developed a biocomputational platform to construct a mathematical model of their interaction network with miRNAs and transcription factors, where the property of dosage compensation emerged for MYC and was dependent on the kinetic parameters of its feedback interactions with three micro-RNAs. These circuits were experimentally validated with a novel genetic tug-of-war technique by overexpressing an exogenous MYC leading to over-expression of the three microR…

Genome instabilityDosage compensationColorectal cancermicroRNACancer cellmedicineCancer researchCancerBiologymedicine.diseaseGene dosageTranscription factor
researchProduct

Aging Successfully: The Role of Genetics and Environment in the Era of the Aging-Boom. Potential Therapeutic Implications

2019

Aging is one of the main health-related challenges in the world. The average life expectancy of the global population at birth is increasing up to 72 years, in 2016 and it increases about two years every decade. The healthcare costs in many countries are very high because of the increased number of unhealthy populations, and the consequent increase of severe age-related disabilities [1]. Therefore, the goal of the future should be the achievement of the so-called “health-span” (healthy-life-span), more than the treatment of age-related disease to prevent the collapse of the health system. In order to achieve this objective, it is necessary to identify new targets and biomarkers and to addre…

GerontologyAgingEye DiseasesLongevityMEDLINEAging Anti-aging strategies DNA methylation Immunesenescence TLR agonist Immunesenescence Melatonin MiRNA Neuroinflammation Vasculoprotection01 natural sciencesBoomEpigenesis Genetic03 medical and health sciencesDrug DiscoveryHumansMedicineMelatonin030304 developmental biologyEpigenesisSettore MED/04 - Patologia GeneralePharmacology0303 health sciencesbusiness.industryToll-Like ReceptorsVaccination0104 chemical sciencesMicroRNAs010404 medicinal & biomolecular chemistryMethotrexateImmune SystembusinessIntroductory Journal ArticleCurrent Pharmaceutical Design
researchProduct

MicroRNAs in solid organ and vascularized composite allotransplantation: Potential biomarkers for diagnosis and therapeutic use

2020

Abstract Nowadays, solid organ transplantation (SOT) is an established treatment for patients with end-organ dysfunction, which dramatically improves the quality-of-life. Vascularized composite allotransplants (VCAs) including hand and face have been reported worldwide over the last 20 years. However, VCAs, differently to SOT, are life-enhancing instead of life-saving and are not routinely performed due to the risk of immune rejection and the adverse effects of immunosuppression. Over the past decade, although considerable improvements in short-term outcomes after allotransplantation have been registered, these results have not been translated into major progress in long-term allograft acce…

Graft Rejectionmedicine.medical_specialtyImmune rejectionmedicine.medical_treatmentBioinformaticsVascularized Composite AllotransplantationOrgan transplantationRNA interferencemicroRNABiomarker; Immune rejection; Micro-RNAs; Organ transplantation; Tolerance; Vascularized composite allotransplantationsmedicineHumansBiomarker discoveryVascularized composite allotransplantationsImmunosuppression TherapyVascularized Composite AllotransplantationTransplantationOrgan transplantationbusiness.industryMicro-RNAsImmunosuppressionBiomarkerBiomarker (cell)MicroRNAsVascularized composite allotransplantations Micro-RNAs Biomarker Immune rejection Organ transplantation TolerancebusinessToleranceBiomarkersAllotransplantation
researchProduct

A stress-responsive miRNA regulates BMP signaling to maintain tissue homeostasis

2021

Adult organisms must sense and adapt to environmental fluctuations. In high-turnover tissues such as the intestine, these adaptive responses require rapid changes in gene expression that, in turn, likely involve posttranscriptional gene control. However, intestinal-tissue-specific microRNA (miRNA)-mediated regulatory pathways remain unexplored. Here, we report the role of an intestinal-specific miRNA, miR-958, that non-cell autonomously regulates stem cell numbers during tissue homeostasis and regeneration in the Drosophila adult midgut. We identify its downstream target cabut, the Drosophila ortholog of mammalian KLF10/11 transcription factors, which mediates this miR-958 function by promo…

Green Fluorescent ProteinsCell CountBiologyBone morphogenetic protein03 medical and health sciencesParacrine signallingBleomycin0302 clinical medicineGenes ReportermicroRNAGene expressionAnimalsDrosophila ProteinsHomeostasisRegenerationTranscription factorTissue homeostasis030304 developmental biology0303 health sciencesMultidisciplinaryRegeneration (biology)Stem CellsBiological SciencesCell biologyMicroRNAsDrosophila melanogasterEnterocytesGene Expression RegulationBone Morphogenetic ProteinsStem cell030217 neurology & neurosurgerySignal TransductionTranscription Factors
researchProduct

Selective MicroRNA-Offset RNA Expression in Human Embryonic Stem Cells

2015

Small RNA molecules, including microRNAs (miRNAs), play critical roles in regulating pluri-potency, proliferation and differentiation of embryonic stem cells. miRNA-offset RNAs (moRNAs) are similar in length to miRNAs, align to miRNA precursor (pre-miRNA) loci and are therefore believed to derive from processing of the pre-miRNA hairpin sequence. Recent next generation sequencing (NGS) studies have reported the presence of moRNAs in human neurons and cancer cells and in several tissues in mouse, including pluripotent stem cells. In order to gain additional knowledge about human moRNAs and their putative development-related expression, we applied NGS of small RNAs in human embryonic stem cel…

HUMAN DICERSmall RNAHuman Embryonic Stem CellsMolecular Sequence Datalcsh:MedicineGene ExpressionBiologyPLURIPOTENCYCell LinemicroRNAGene expressionmiRNA-offset RNAsELEMENTSHumansSmall nucleolar RNAlcsh:ScienceInduced pluripotent stem cellGene LibraryGENE-EXPRESSIONGeneticsBinding SitesMultidisciplinaryBase Sequenceta1184Gene Expression ProfilingMATURE MICRORNASMORNASlcsh:RComputational BiologyHigh-Throughput Nucleotide SequencingRNAMolecular Sequence AnnotationRNA sequencingembryonic stem cellsEmbryonic stem cellmicroRNAsCell biologyMicroRNAsMIRNASDISCOVERYMOUSE ES CELLSRNA Small Untranslatedlcsh:Q3111 BiomedicineRNA extractionFEEDER CELLSSequence AlignmentResearch ArticlePLOS ONE
researchProduct

HUMAN LIVER AND MICRORNA PROFILING:EFFECTS OF DONOR AND RECIPIENT AGE-MISMATCH IN TRASPLANT.

2012

HUMAN LIVERMICRORNA PROFILINGTRASPLANTSettore MED/05 - Patologia ClinicaEFFECTS OF DONOR AND RECIPIENT AGE-MISMATCH
researchProduct

P0926 : Representation of human non-alcoholic fatty liver disease in murine models

2015

COX-2 enhances insulin signaling. Finally, the relationship between COX-2 and the miRNAs was confirmed in NAS. Conclusions: COX-2 represses the expression of miRNAs implicated in the insulin signaling pathway via a PI3K/p300-dependent upregulation of DDX5, and by modulating the activity of the Drosha complex. Our study proposes a novel miRNA-dependent mechanism through which COX-2 promotes insulin signaling in liver cells.

HepatologyDDX5Mechanism (biology)Fatty liverBiologymedicine.diseaseCell biologyInsulin receptorchemistry.chemical_compoundDownregulation and upregulationchemistrymicroRNAbiology.proteinmedicineDroshaPI3K/AKT/mTOR pathwayJournal of Hepatology
researchProduct

Epigenetic regulation of methionine adenosyltransferase 1A: a role for MicroRNA-based treatment in liver cancer?

2013

MicroRNAs (miRNAs) and methionine adenosyltransferase 1A (MAT1A) are dysregulated in hepatocellular carcinoma (HCC), and reduced MAT1A expression correlates with worse HCC prognosis. Expression of miR-664, miR-485-3p, and miR-495, potential regulatory miRNAs of MAT1A, is increased in HCC. Knockdown of these miRNAs individually in Hep3B and HepG2 cells induced MAT1A expression, reduced growth, and increased apoptosis, while combined knockdown exerted additional effects on all parameters. Subcutaneous and intraparenchymal injection of Hep3B cells stably overexpressing each of this trio of miRNAs promoted tumorigenesis and metastasis in mice. Treatment with miRNA-664 (miR-664), miR-485-3p, and…

HepatologymicroRNAmedicineCancer researchMethionine adenosyltransferase 1AEpigeneticsBiologyLiver cancermedicine.diseasedigestive system diseasesResearch ArticleHepatology (Baltimore, Md.)
researchProduct

Efficient Reprogramming of Human Fibroblasts and Blood-Derived Endothelial Progenitor Cells Using Nonmodified RNA for Reprogramming and Immune Evasion

2015

mRNA reprogramming results in the generation of genetically stable induced pluripotent stem (iPS) cells while avoiding the risks of genomic integration. Previously published mRNA reprogramming protocols have proven to be inconsistent and time-consuming and mainly restricted to fibroblasts, thereby demonstrating the need for a simple but reproducible protocol applicable to various cell types. So far there have been no published reports using mRNA to reprogram any cell type derived from human blood. Nonmodified synthetic mRNAs are immunogenic and activate cellular defense mechanisms, which can lead to cell death and inhibit mRNA translation upon repetitive transfection. Hence, to overcome RNA…

Homeobox protein NANOGCellular Reprogramming TechniquesInduced Pluripotent Stem CellsVaccinia virusFibroblastsBiologyTransfectionLIN28Molecular biologyCell biologyKruppel-Like Factor 4MicroRNAsSOX2KLF4GeneticsHumansMolecular MedicineCellular Reprogramming TechniquesRNA MessengerProgenitor cellInduced pluripotent stem cellMolecular BiologyReprogrammingEndothelial Progenitor CellsImmune EvasionHuman Gene Therapy
researchProduct